| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $438,175,021 ) (Continued on the next page) |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA274251 | Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer | 001 | 2 | NIH | 5/22/2025 | $56,919 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EB036536 | Advancing Multiple Myeloma Prognostication and Monitoring through AI-Powered Comprehensive Imaging | 000 | 1 | NIH | 7/28/2025 | $755,336 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA274251 | Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer | 000 | 2 | NIH | 2/12/2025 | $512,262 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | DP2AI192719 | Engineering Metal Ion-Immunity Crosstalk for Metalloimmunotherapy | 000 | 1 | NIH | 8/7/2025 | $507,000 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21CA301237 | Characterizing DNA Methylation Dynamics in Trisomy 21-Associated Hematopoiesis and Leukemia | 001 | 1 | NIH | 8/28/2025 | -$2,123 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21CA301237 | Characterizing DNA Methylation Dynamics in Trisomy 21-Associated Hematopoiesis and Leukemia | 000 | 1 | NIH | 8/7/2025 | $464,577 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA276087 | Immunogenomic predictors of outcomes in patients with locally advanced cervical cancer treated with immunotherapy and chemoradiation | 002 | 4 | NIH | 7/1/2025 | $529,039 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K23DA061256 | Pediatric Emergency Department-initiated Support program To Link Care (PEDS-TLC) for youth with substance use | 001 | 1 | NIH | 7/25/2025 | $0 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI188112 | The role of the mRNA-based or Newcastle disease virus (NDV)-based vaccine platform in mucosal B cell priming and recirculation | 000 | 1 | NIH | 7/23/2025 | $464,750 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K23DA061256 | Pediatric Emergency Department-initiated Support program To Link Care (PEDS-TLC) for youth with substance use | 000 | 1 | NIH | 7/11/2025 | $194,111 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01DA053629 | Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice | 001 | 5 | NIH | 4/8/2025 | $164,155 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI188112 | The role of the mRNA-based or Newcastle disease virus (NDV)-based vaccine platform in mucosal B cell priming and recirculation | 001 | 1 | NIH | 8/7/2025 | $0 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01DA053629 | Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice | 000 | 5 | NIH | 2/26/2025 | $1,477,403 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31NS134301 | Theta Phase-Locked Stimulation of Entorhinal-Hippocampal Inputs in Healthy and Epileptic Mice | 001 | 2 | NIH | 9/8/2025 | $564 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31NS134301 | Theta Phase-Locked Stimulation of Entorhinal-Hippocampal Inputs in Healthy and Epileptic Mice | 000 | 2 | NIH | 3/14/2025 | $47,374 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HD102614 | FUNCTIONAL CHARACTERIZATION OF NOVEL DETERMINANTS OF HOLOPROSENCEPHALY (HPE) | 001 | 5 | NIH | 5/1/2025 | $36,335 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139395 | Genetic risk and molecular characterization of Diabetic Kidney Disease | 001 | 2 | NIH | 5/21/2025 | $33,799 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HD102614 | FUNCTIONAL CHARACTERIZATION OF NOVEL DETERMINANTS OF HOLOPROSENCEPHALY (HPE) | 000 | 5 | NIH | 2/19/2025 | $327,015 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139395 | Genetic risk and molecular characterization of Diabetic Kidney Disease | 000 | 2 | NIH | 3/4/2025 | $304,201 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EY027301 | Characterization of vascular responses to intravitreal anti-VEGF injections in diabetic retinopathy | 002 | 7 | NIH | 7/10/2025 | $697,579 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL171695 | Comprehensive Patient-centered Home-based care coaching for COPD self-management | 000 | 2 | NIH | 2/26/2025 | $610,261 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K99AI193231 | Mapping inflammatory bowel disease variants to genes and functional phenotypes in human macrophages | 000 | 1 | NIH | 8/5/2025 | $132,677 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | T42OH008422 | OCCUPATIONAL SAFETY AND HEALTH EDUCATION AND RESEARCH CENTERS (T42) | 00 | 20 | CDC | 6/27/2025 | $1,603,484 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01OH010401 | Pulmonary Diseases in WTC Workers: Symptoms, Function, and Chest CT Correlates | 00 | 12 | CDC | 7/2/2025 | $599,645 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U24AG087563 | The BrainCellQTL consortium: QTL mapping in the human brain at the single cell level | 000 | 2 | NIH | 3/27/2025 | $900,000 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U24AG087563 | The BrainCellQTL consortium: QTL mapping in the human brain at the single cell level | 001 | 2 | NIH | 4/15/2025 | $136,733 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U24AG087563 | The BrainCellQTL consortium: QTL mapping in the human brain at the single cell level | 001 | 2 | NIH | 4/15/2025 | $100,000 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01NS139213 | Mount Sinai Center for Undiagnosed Diseases | 001 | 2 | NIH | 8/8/2025 | $816,633 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01NS139213 | Mount Sinai Center for Undiagnosed Diseases | 002 | 2 | NIH | 8/22/2025 | -$800,000 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01NS139213 | Mount Sinai Center for Undiagnosed Diseases | 002 | 2 | NIH | 8/22/2025 | $800,000 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U24AG087563 | The BrainCellQTL consortium: QTL mapping in the human brain at the single cell level | 000 | 2 | NIH | 3/27/2025 | $1,230,603 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21EY037046 | Reconstruction of a human blood-retina barrier and perfused vascular system to investigate the role of APOE variants in age-related macular degeneration | 000 | 1 | NIH | 2/3/2025 | $253,500 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA301057 | Dissecting the hematopoietic pathways governing age-associated pathogenic myelopoiesis | 000 | 1 | NIH | 2/27/2025 | $680,334 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI185102 | Development of broadly neutralizing human monoclonal antibodies against henipaviruses | 000 | 1 | NIH | 2/26/2025 | $809,614 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139631 | Nrf2 and the expansion and preservation of beta cell mass | 001 | 2 | NIH | 7/21/2025 | $73,581 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | RF1MH132789 | Establishing the anatomical and functional mechanisms of white matter deep brain stimulation | 000 | 3 | NIH | 8/28/2025 | $2,399,556 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HD097088 | Aberrant chromatin regulatory mechanisms in Down syndrome brain | 001 | 7 | NIH | 8/8/2025 | $725,919 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21OH012948 | Update of the WTC Cancer Tissue Biobank | 00 | 1 | CDC | 8/4/2025 | $250,953 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R03AG095793 | Out-of-pocket spending and burdensome care for older adults with serious illness | 000 | 1 | NIH | 8/20/2025 | $422,500 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | T32HL176457 | Cardiovascular Science Training Program (CSTP) | 000 | 1 | NIH | 8/14/2025 | $447,977 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HD118270 | Targeting succinyl-CoA:glutarate-CoA transferase as a novel therapeutic strategy for glutaric aciduria type 1 | 000 | 1 | NIH | 7/25/2025 | $726,266 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI187947 | Kinase activity rewiring in T cell trans-differentiation | 000 | 1 | NIH | 7/7/2025 | $464,750 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM160031 | Investigating the Mechanisms of Brain-Heart Communication Under Stress | 000 | 1 | NIH | 8/14/2025 | $420,834 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK112978 | The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease | 002 | 7 | NIH | 6/11/2025 | $64,146 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K99DK140510 | Elucidate the role of higher-order chromatin organization during terminal differentiation in mouse erythropoiesis | 000 | 1 | NIH | 8/15/2025 | $90,000 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK112978 | The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease | 000 | 7 | NIH | 3/5/2025 | $577,304 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | H79TI085978 | Adapting and implementing opioid-sparing pain management protocols across Mount Sinai Health System Emergency Departments | 003 | 2 | SAMHSA | 7/15/2025 | $500,000 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | UH3AG083258 | Research Infrastructure for the study of Alzheimer's Disease and Alzheimer's Disease-related dementias in older Asian Americans | 000 | 3 | NIH | 8/25/2025 | $1,223,120 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F30HL182178 | Role of RNA-binding protein DDX3X in the endocardium during development and disease | 000 | 1 | NIH | 8/30/2025 | $54,538 |
|
